BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2893412)

  • 1. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
    Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P; Martin P; Soubrié P; Simon P
    Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE; Fleck-Kandath C; Mansbach RS
    Pharmacol Biochem Behav; 1988 Jul; 30(3):723-7. PubMed ID: 2905470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.
    Darrow EJ; Strahlendorf HK; Strahlendorf JC
    Eur J Pharmacol; 1990 Jan; 175(2):145-53. PubMed ID: 1968842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
    Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
    Ryan CN; Evenden JL; Petterson M
    Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
    Mendelson SD; Gorzalka BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
    Gilbert F; Brazell C; Tricklebank MD; Stahl SM
    Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
    Mansbach RS; Geyer MA
    Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of taste and food texture on the feeding responses induced by 8-OH-DPAT and gepirone.
    Fletcher PJ; Zack MH; Coscina DV
    Psychopharmacology (Berl); 1991; 104(3):302-6. PubMed ID: 1681556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
    Martin P; Beninger RJ; Hamon M; Puech AJ
    Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.